These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 4139232)
21. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells. Reininger L; Radaszkiewicz T; Kosco M; Melchers F; Rolink AG J Exp Med; 1992 Nov; 176(5):1343-53. PubMed ID: 1402680 [TBL] [Abstract][Full Text] [Related]
22. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Winfield JB; Winchester RJ; Wernet P; Fu SM; Kunkel HG Arthritis Rheum; 1975; 18(1):1-8. PubMed ID: 46753 [TBL] [Abstract][Full Text] [Related]
23. Studies of tolerance to DNA in NZB/NZW F1 mice. Tanphaichtr K; Hahn BH J Immunol; 1977 Jul; 119(1):330-6. PubMed ID: 301536 [TBL] [Abstract][Full Text] [Related]
24. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771 [TBL] [Abstract][Full Text] [Related]
25. Glycosylation is not required for membrane localization or secretion of IgM in a mouse B cell lymphoma. Sibley CH; Wagner RA J Immunol; 1981 May; 126(5):1868-73. PubMed ID: 6783700 [TBL] [Abstract][Full Text] [Related]
26. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid. Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582 [TBL] [Abstract][Full Text] [Related]
27. A mouse monoclonal antibody specific for an allotypic determinant of the Igha allele of murine IgM: genetic and functional analysis of Igh-6a epitopes using anti-IgM monoclonal antibodies. Sieckmann DG; Stall AM; Subbarao B Hybridoma; 1991 Feb; 10(1):121-35. PubMed ID: 1709612 [TBL] [Abstract][Full Text] [Related]
28. Treatment of NZB/NZW mice with total lymphoid irradiation: long-lasting suppression of disease without generalized immune suppression. Kotzin BL; Arndt R; Okada S; Ward R; Thach AB; Strober S J Immunol; 1986 May; 136(9):3259-65. PubMed ID: 2937842 [TBL] [Abstract][Full Text] [Related]
29. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma. Weiner GJ; Kaminski MS J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325 [TBL] [Abstract][Full Text] [Related]
30. Thymus-antigen- and immunoglobulin- positive cells in lymph-nodes, thymus, and malignant lymphomas of NZB/NZW mice. Greenspan JS; Gutman GA; Talal N; Weissman IL; Sugai S Clin Immunol Immunopathol; 1974 Sep; 3(1):32-51. PubMed ID: 4611671 [No Abstract] [Full Text] [Related]
31. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. Merino R; Iwamoto M; Fossati L; Izui S J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378 [TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity. Ciavarra RP; Vitetta ES; Forman J J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362 [TBL] [Abstract][Full Text] [Related]
33. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice. DeHeer DH; Edgington TS J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901 [TBL] [Abstract][Full Text] [Related]
34. Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitro. Miura T; Ghanta VK; Hiramoto RN Cancer Invest; 1990; 8(1):17-25. PubMed ID: 2350718 [TBL] [Abstract][Full Text] [Related]
35. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. King CA; Wills MR; Hamblin TJ; Stevenson FK Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858 [TBL] [Abstract][Full Text] [Related]
36. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice. Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583 [TBL] [Abstract][Full Text] [Related]
37. Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens. Binz H; Wigzell H J Exp Med; 1975 Jul; 142(1):197-211. PubMed ID: 50400 [TBL] [Abstract][Full Text] [Related]
38. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness. Liou LB; Wu MW; Chao WJ Scand J Immunol; 2009 May; 69(5):447-56. PubMed ID: 19508376 [TBL] [Abstract][Full Text] [Related]
39. Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens. Thielemans K; Rothbard JB; Levy S; Levy R J Exp Med; 1985 Jul; 162(1):19-34. PubMed ID: 3925067 [TBL] [Abstract][Full Text] [Related]
40. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells. Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]